Mexico vs Morocco: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Mexico
78.0%
in 2025
Morocco
77.0%
in 2025
Mexico rank
123rd
Morocco rank
124th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Mexico
- Morocco
How they compare
Mexico currently reports 78.0% against 77.0% in Morocco, a difference of 1.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Mexico ahead.
Mexico ranks 123rd and Morocco ranks 124th of 194 countries.
Across the 3 decades both report, Mexico averaged higher in 2 and Morocco in 1.
Head to head by decade
| Decade | Mexico | Morocco | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30.0% | 0.0% | 30.0% | Mexico |
| 2010s | 91.8% | 75.5% | 16.3% | Mexico |
| 2020s | 79.3% | 89.3% | 10.0% | Morocco |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Mexico or Morocco?
- Mexico, at 78.0% against 77.0% in Morocco as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Mexico and Morocco?
- 1.0%, with Mexico ahead.
- How many years of comparable data are there for Mexico and Morocco?
- 18 years are reported by both, from 2008 to 2025.
- How do Mexico and Morocco rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Mexico ranks 123rd and Morocco ranks 124th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.